Management of Infected Stage 3 Sacral Pressure Ulcers

Empiric Antibiotic Selection

Initiate broad‑spectrum empiric therapy that covers Gram‑positive cocci (including MRSA when local epidemiology warrants), Gram‑negative bacilli, and anaerobes, together with urgent surgical debridement. 1
First‑line regimen: piperacillin‑tazobactam + vancomycin, which provides coverage against Staphylococcus aureus, Enterococcus spp., Proteus mirabilis, Escherichia coli, Pseudomonas spp., Peptococcus spp., Bacteroides fragilis, and Clostridium perfringens—the typical pathogens in infected pressure ulcers. 1
Add vancomycin or daptomycin when local MRSA prevalence exceeds 20 % or when the patient has risk factors such as recent healthcare exposure, prior antibiotic use, or residence in a long‑term care facility. 1
Daptomycin is preferred over vancomycin in patients with renal impairment or when the vancomycin MIC is ≥ 2 µg/mL. 2
Linezolid is not recommended for empirical use in this setting. 2
A carbapenem alone (imipenem, meropenem, or ertapenem) offers adequate polymicrobial coverage, including anaerobes, and can be used as an alternative first‑line agent. 3
For patients with β‑lactam allergy or when carbapenems are unavailable, ceftriaxone + metronidazole is an acceptable alternative. 3
Fluoroquinolone (levofloxacin or ciprofloxacin) + metronidazole may be used as another alternative regimen. 3

Surgical debridement is mandatory; antibiotics alone are insufficient for infected pressure ulcers. 1
During debridement, obtain deep tissue or abscess‑fluid specimens for culture to enable targeted antimicrobial therapy. 4
Urgent surgical consultation is indicated for deep abscesses, extensive tissue involvement, crepitus, or systemic signs of infection. 5
Deep intra‑operative tissue or fluid should be collected for semiquantitative cultures. 4
If debridement is delayed, the Levine swab technique can be employed, although it is less reliable than tissue cultures. 4
Superficial wound swabs should be avoided because they do not accurately reflect the deep‑tissue pathogen profile. 6

Standard therapy duration is 2–4 weeks for moderate‑to‑severe soft‑tissue infections when adequate debridement has been performed. 5
The exact length depends on the completeness of debridement, presence of cellulitis, and the patient’s clinical response. 5
Extend therapy to 6 weeks if osteomyelitis is present and surgical debridement with flap reconstruction has been carried out. 4
Continue antibiotics until clinical signs of infection resolve (e.g., reduced erythema, warmth, purulent drainage, and systemic symptoms); therapy does not need to wait for complete wound healing. 5
If no clinical improvement is observed after 7 days, discontinue antibiotics for 2–3 days, repeat cultures, and then initiate an alternative regimen based on new results. 5

Narrow the antimicrobial spectrum once culture results and susceptibilities are available. 5
After clinical improvement and if the patient can tolerate oral intake, switch from intravenous to highly bioavailable oral agents (e.g., fluoroquinolones, linezolid, clindamycin). 5
Ongoing monitoring is required to detect treatment failure, which would necessitate broader coverage or alternative agents. 5

Pressure‑ulcer infections are invariably polymicrobial, typically comprising aerobic gram‑negative bacilli (e.g., E. coli, Proteus, Pseudomonas), gram‑positive cocci (e.g., Staphylococcus spp., Streptococcus spp.), and anaerobes (e.g., Bacteroides, Peptostreptococcus, Clostridium perfringens)【7】【8】【9】.

For an elderly nursing‑home resident with an infected sacral pressure ulcer and unknown MRSA colonization, empiric oral therapy should cover MRSA and the polymicrobial flora using one of the following combinations:

Trimethoprim‑sulfamethoxazole provides MRSA coverage and activity against common gram‑negative pathogens【10】.
Amoxicillin‑clavulanate covers streptococci, methicillin‑susceptible S. aureus, anaerobes, and many gram‑negative organisms【10】.
The TMP‑SMX + amoxicillin‑clavulanate combination addresses the full polymicrobial spectrum expected in pressure‑ulcer infections【7】【8】.
Doxycycline has activity against MRSA as well as a broad range of gram‑positive and gram‑negative organisms【10】.
Levofloxacin or moxifloxacin offers excellent gram‑negative coverage and reasonable gram‑positive activity【10】.
Metronidazole is essential for anaerobic coverage, particularly against Bacteroides species【10】.
Moxifloxacin possesses superior anaerobic activity compared with levofloxacin, but adding metronidazole ensures complete anaerobic coverage【10】.

Surface swab cultures are not indicated for diagnosing infected pressure ulcers because they cannot distinguish colonization from infection【8】【9】.
Deep tissue specimens obtained during surgical debridement constitute the gold‑standard for microbiologic diagnosis【8】【9】.